Transforming Viral Vector Manufacturing With Next-Generation CGMP Plasmids Platform
Next-generation CGMP plasmid production platforms offer significant advantages for viral vector manufacturing, enabling greater efficiency, cost reduction, and improved scalability. In this webinar, experts will explore key innovations in plasmid design and production, highlighting how these advancements can directly enhance biomanufacturing workflows.
Topics will include strategies for optimizing plasmid production to streamline operations and lower costs, approaches to boosting viral vector yields by addressing common manufacturing bottlenecks, and methods for ensuring quality and consistency to support safer, more effective cell and gene therapies.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.